Presentation Information
[LS-39-2]How Satralizumab changed treatment strategy in NMOSD- Real World Evidence from Japan -
Kazuo Fujihara (Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine／Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan)